Genomadix Inc. Announces Know-How License Agreement With Mayo Clinic
Genomadix Inc. Announces Know-How License Agreement with Mayo Clinic OTTAWA, ON, Aug. 29, 2022 /CNW/ – Genomadix today announced it has entered into a know-how license agreement and stock purchase agreement with Mayo Clinic to advance its point of care molecular analyzer technology. The Genomadix CubeTM uses polymerase chain reaction (PCR) technology in a small and portable […]
Genomadix Inc. Announces Know-How License Agreement With Mayo Clinic Read More »
